Mitigating Chemotherapy Toxicities in Breast Cancer: The Potential of Arglabin Therapy

Volume 26, Issue 2, February 2025, Pages 359-360

Umme Ambreen; Muhammad Umar Ahsan

• View Article
• PDF 290.58 K

A Polyherbal Ashwagandha Formulation Exhibits Adjunctive Antitumor Efficacy Against U266 Myeloma Cells by Multi-Strategic Cytotoxic Effects: An Experimental Approach

Volume 24, Issue 11, November 2023, Pages 3705-3714

Shraddha Kapoor; Nidhi Gupta; Alpana Sharma

• View Article
• PDF 2.34 M

Sequential Chemoradiotherapy Compared to Radiotherapy in Endometrial Carcinoma

Volume 21, Issue 5, May 2020, Pages 1327-1332

Omima Elemam; Seham Abdelkhalek; Doaa Abdelmoety; Engy Aboelnaga; Reem Baraka; Ahmed Zeeneldine

• View Article
• PDF 387.05 K

Safety Analysis of Adjuvant Chemotherapy with Docetaxel Administered with or without Anthracyclines to Early Stage Breast Cancer Patients: Combined Results from the Asia- Pacific Breast Initiatives I and II

Volume 17, Issue 2, February 2016, Pages 697-702

• View Article
• PDF 652.05 K

Adjuvant Chemotherapy and Prognostic Factors in Stage II Colon Cancer - Izmir Oncology Group Study

Volume 16, Issue 6, June 2015, Pages 2413-2418

• View Article
• PDF 639.81 K

Recurrence Risk and Prognostic Parameters in Stage I Rectal Cancers

Volume 15, Issue 13, December 2014, Pages 5337-5341

• View Article
• PDF 365.25 K

Association of Human Epidermal Growth Factor Receptor-2 Expression and Clinicopathological Findings in Patients with Colorectal Cancer

Volume 13, Issue 12, December 2012, Pages 6221-6225

• View Article
• PDF 651.53 K

Preoperative Prognostic Factors and Effects of Adjuvant Therapy on Outcomes of Early Stage Cervical Cancer in Iran

Volume 10, Issue 4, April 2009, Pages 613-618

• View Article
• PDF 35.36 K